PMC6166370_01
Evolution of B-crosslaps after denosumab discontinuation.
CRIRH2018-5432751.001.jpg
PMC6166370_01_CRIRH2018-5432751.001.jpg
fig1
CTX, measured in August 2017, were extremely high at 2070 ng/l (Figure 1).